IL33 and atherosclerosis: Recently, it was reported that deficiency of the endogenously produced IL-33 and its receptor ST2 did not impact the development of atherosclerosis in ApoE-deficient mice [35], which might contribute to the conclusion that the deficiency of endogenous IL-33 signaling had no impact on the Th1/Th2 cytokine profile.